Stock Quote

AstraZeneca resumes U.S. Covid-19 vaccine trial and Johnson & Johnson prepares to do same

AstraZeneca has resumed the U.S. trial of its experimental Covid-19 vaccine after approval by U.S. regulators, and an oversight panel has recommended that Johnson & Johnson resume its trial as well, the companies said on Friday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.